J
$ Value
$13K
Shares
256
Price
$49
Filed
Mar 3
Insider
Name
Swayze Eric
Title
EVP Research
CIK
0001791058
Roles
Officer
Transaction Details
Transaction Date
2026-02-27
Code
J
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
32,361
Footnotes
Reporting shares purchased under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on February 27, 2026. These shares may not be sold until August 27, 2026.
Filing Info
Swayze Eric's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-27 | IONS | J | $13K |
| 2026-02-13 | IONS | ▼ | $770K |
| 2026-02-13 | IONS | ▼ | $509K |
| 2026-01-30 | IONS | ▼ | $512K |
| 2026-01-29 | IONS | A | $0 |
| 2026-01-16 | IONS | ▼ | $745K |
| 2026-01-16 | IONS | ▼ | $4K |
| 2026-01-15 | IONS | M | $0 |
| 2026-01-15 | IONS | M | $0 |
| 2026-01-15 | IONS | A | $0 |
Other Insiders at IONS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| PARSHALL B LYNNE | — | $795K | 2026-04-15 |
|
BENNETT C FRANK
EVP, Chief Scientific Officer
|
— | $14.3M | 2026-03-03 |
|
HOUGEN ELIZABETH L
EVP, Finance & CFO
|
— | $16.9M | 2026-03-17 |
| KLEIN JOSEPH III | — | $3.4M | 2026-04-01 |
| LOSCALZO JOSEPH | — | $83K | 2026-03-04 |
|
Monia Brett P
Chief Executive Officer
|
— | $19.8M | 2026-03-10 |
|
O'NEIL PATRICK R.
EVP CLO & General Counsel
|
— | $1.3M | 2026-03-09 |
| Diaz Allene M. | — | $4.4M | 2026-03-03 |
|
Swayze Eric
EVP Research
|
— | $1.8M | 2026-02-13 |
|
Jenne Kyle
EVP, Chf GL Pdt Str Ofcr
|
— | $3.2M | 2026-04-16 |
|
Baroldi Joseph
EVP, Chief Business Officer
|
— | $1.4M | 2026-04-16 |
|
Schneider Eugene
EVP, Chf Clinical Develop Ofcr
|
— | $928K | 2026-03-19 |
|
Birchler Brian
EVP, Corp and Development Ops
|
— | $586K | 2026-04-16 |
|
Devers Shannon L.
EVP, Chief Human Resources Ofc
|
— | $2.1M | 2026-04-02 |